Skip to main content
. 2022 May 24;10(2):26. doi: 10.3390/medsci10020026

Figure 4.

Figure 4

(A). Profile of CNA count on subtypes of metastatic melanoma (CMInline graphic; HNMInline graphic; UMInline graphic; AM/MMInline graphic). (B). Progression-free survival (PFS) of CNA low (red line) and high (blue line) in the total metastatic melanoma cohort. Kaplan–Meier survival curves with a log-rank test were used for the analysis. ns, not significant.